Biocon inches up on entering into agreement to acquire stake in HRTPL

24 Nov 2020 Evaluate

Biocon is currently trading at Rs. 422.60, up by 2.70 points or 0.64% from its previous closing of Rs. 419.90 on the BSE.

The scrip opened at Rs. 422.00 and has touched a high and low of Rs. 425.30 and Rs. 421.00 respectively. So far 23367 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 477.90 on 09-Oct-2020 and a 52 week low of Rs. 235.80 on 19-Mar-2020.

Last one week high and low of the scrip stood at Rs. 429.70 and Rs. 415.00 respectively. The current market cap of the company is Rs. 50388.00 crore.

The promoters holding in the company stood at 60.67%, while Institutions and Non-Institutions held 22.98% and 16.35% respectively.

Biocon has entered into an agreement for acquisition of 26% equity stake on a fully diluted basis in Hinduja Renewables Two (HRTPL), a special purpose vehicle formed for the purpose of power generation and developing a captive power plant as per Electricity laws. HRTPL was incorporated on September 25, 2020, which will engage in the business of power generation and will develop a 19.77 MW wind power plant (captive) at Raichur District of Karnataka.

Biocon is India’s largest and Asia’s leading Biotechnology Company with a strategic focus on biopharmaceuticals and research services. It is a fully integrated, innovation driven biopharma enterprise offering affordable solutions for chronic diseases to patient's worldwide.

Biocon Share Price

317.90 1.75 (0.55%)
01-Nov-2024 18:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1858.70
Dr. Reddys Lab 1258.55
Cipla 1559.20
Lupin 2198.25
Zydus Lifesciences 1004.00
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.